{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:18:05Z","timestamp":1778743085385,"version":"3.51.4"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2005,1,15]],"date-time":"2005-01-15T00:00:00Z","timestamp":1105747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2005,1,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Sabin strains used in the manufacture of oral polio vaccine (OPV) replicate in the human organism and can give rise to vaccine-derived polioviruses. The increased neurovirulence of vaccine derivatives has been known since the beginning of OPV use, but their ability to establish circulation in communities has been recognized only recently during the latest stages of the polio eradication campaign. This important observation called for studies of their emergence and evolution as well as extensive surveillance to determine the scope of this phenomenon. Here, we present the results of a study of vaccine-derived isolates from an immunocompromised poliomyelitis patient, the contacts, and the local sewage. All isolates were identified as closely related and slightly evolved vaccine derivatives with a recombinant type 2\/type 1 genome. The strains also shared several amino acid substitutions including a mutation in the VP1 protein that was previously shown to be associated with the loss of attenuation. Another mutation in the VP3 protein resulted in altered immunological properties of the isolates, possibly facilitating virus spread in immunized populations. The patterns and rates of the accumulation of synonymous mutations in isolates collected from the patient over the extended period of excretion suggest either a substantially nonuniform rate of mutagenesis throughout the genome, or, more likely, the strains may have been intratypic recombinants between coevolving derivatives with different degrees of divergence from the vaccine parent. This study provides insight into the early stages of the establishment of circulation by runaway vaccine strains.<\/jats:p>","DOI":"10.1128\/jvi.79.2.1062-1070.2005","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T03:05:49Z","timestamp":1103598349000},"page":"1062-1070","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":48,"title":["Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine"],"prefix":"10.1128","volume":"79","author":[{"given":"E. A.","family":"Cherkasova","sequence":"first","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland"},{"name":"A. N. Belozersky Institute of Physical-Chemical Biology, Moscow State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Yakovenko","sequence":"additional","affiliation":[{"name":"A. N. Belozersky Institute of Physical-Chemical Biology, Moscow State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. V.","family":"Rezapkin","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Korotkova","sequence":"additional","affiliation":[{"name":"A. N. Belozersky Institute of Physical-Chemical Biology, Moscow State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. E.","family":"Ivanova","sequence":"additional","affiliation":[{"name":"M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow Region"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. P.","family":"Eremeeva","sequence":"additional","affiliation":[{"name":"M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow Region"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. I.","family":"Krasnoproshina","sequence":"additional","affiliation":[{"name":"I. I. Mechnikov Institute of Vaccines and Sera, Moscow"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. I.","family":"Romanenkova","sequence":"additional","affiliation":[{"name":"St. Petersburg Pasteur Institute, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. R.","family":"Rozaeva","sequence":"additional","affiliation":[{"name":"St. Petersburg Pasteur Institute, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sirota","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. I.","family":"Agol","sequence":"additional","affiliation":[{"name":"A. N. Belozersky Institute of Physical-Chemical Biology, Moscow State University"},{"name":"M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow Region"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Chumakov","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Agol V. I. G. A. Belov E. A. Cherkasova G. V. Gavrilin M. S. Kolesnikova L. I. Romanova and E. A. Tolskaya. 2001. Some problems of molecular biology of poliovirus infection relevant to pathogenesis viral spread and evolution p. 43-50. In F. Brown (ed.) Progress in polio eradication: vaccine strategies for the end game vol. 105. S. Karger Basel Switzerland."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0003"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18708-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.9.4876-4883.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18974-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(88)90113-4"},{"key":"e_1_3_2_8_2","first-page":"874","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Public health dispatch: acute flaccid paralysis associated with circulating vaccine-derived polioviruses\u2014Philippines. 2001. Morb. Mortal. Wkly. Rep.50:874-875.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1633511100"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6791-6799.2002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.13.5740-5751.2001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.401"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(71)80313-X"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/13.7.403"},{"key":"e_1_3_2_16_2","first-page":"109","volume":"44","year":"2000","unstructured":"Friedrich, F. 2000. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus. Acta Virol.44:109-117.","journal-title":"Acta Virol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.16.7381-7390.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7758-7768.1997"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-8-1819"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19518-0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(01)00143-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2893-2899.1998"},{"key":"e_1_3_2_24_2","first-page":"16","volume":"82","year":"2004","unstructured":"Kew, O. M., P. F. Wright, V. I. Agol, F. Delpeyroux, H. Shimizu, N. Nathanson, and M. A. Pallansch. 2004. Circulating vaccine-derived polioviruses: current state of knowledge. Bull. W. H. O.82:16-23.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/379791"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.23.12460-12465.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890350415"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1003"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.10921-10928.2002"},{"key":"e_1_3_2_31_2","unstructured":"Minor P. 2001. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies p. 75-80. In F. Brown (ed.) Progress in polio eradication: vaccine strategies for the end game vol. 105. S. Karger Basel Switzerland."},{"key":"e_1_3_2_32_2","unstructured":"Biologicals"},{"key":"e_1_3_2_33_2","first-page":"512","volume":"34","year":"1962","unstructured":"Riordan, J. 1962. Isolation of enteroviruses from sewage before and after vaccine administration. Yale J. Biol. Med.34:512-520.","journal-title":"Yale J. Biol. Med."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.10.3729-3734.2000"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(84)90084-6"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.10.2562-2566.1995"},{"key":"e_1_3_2_37_2","unstructured":"World Health Organization. 1997. Manual for the virologic investigation of poliomyelitis. W.H.O.\/EPI\/GEN\/97.1. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_38_2","unstructured":"World Health Organization. 1998. Report of the Second Meeting of the Technical Consultation Group for Global Eradication of Poliomyelitis. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_39_2","first-page":"241","volume":"77","year":"2002","unstructured":"World Health Organization. 2002. Paralytic poliomyelitis in Madagascar. Wkly. Epidemiol. Rec.77:241-242.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_40_2","first-page":"138","volume":"17","year":"2003","unstructured":"World Health Organization. 2003. Progress towards global eradication of poliomyelitis. Wkly. Epidemiol. Rec.17:138-144.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_41_2","unstructured":"Wood D. J. 2001. The scientific basis for stopping polio immunisation\u2014issues and challenges p. 69-72. In F. Brown (ed.) Progress in polio eradication: vaccine strategies for the end game vol. 105. S. Karger Basel Switzerland."},{"key":"e_1_3_2_42_2","first-page":"347","volume":"78","year":"2000","unstructured":"Wood, D. J., R. W. Sutter, and W. R. Dowdle. 2000. Stopping poliovirus vaccination after eradication: issues and challenges. Bull. W. H. O.78:347-357.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_43_2","first-page":"152","volume":"87","year":"1975","unstructured":"Wyatt, H. V. 1975. Risk of live poliovirus in immunodeficient children. J. Pediatr.87:152-153.","journal-title":"J. Pediatr."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(91)90107-7"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.2.1062-1070.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.2.1062-1070.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T09:58:53Z","timestamp":1646474333000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.79.2.1062-1070.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1,15]]}},"alternative-id":["10.1128\/JVI.79.2.1062-1070.2005"],"URL":"https:\/\/doi.org\/10.1128\/jvi.79.2.1062-1070.2005","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,15]]},"assertion":[{"value":"2004-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}